| Primary |
| Arrhythmia |
15.2% |
| Hypertension |
14.7% |
| Cardiac Failure |
12.5% |
| Neuralgia |
8.2% |
| Constipation |
6.0% |
| Pain |
5.4% |
| Pneumonia |
4.9% |
| Asthma |
3.8% |
| Myocardial Infarction |
3.3% |
| Angina Pectoris |
2.7% |
| Extrasystoles |
2.7% |
| Hyperlipidaemia |
2.7% |
| Osteoporosis |
2.7% |
| Ventricular Extrasystoles |
2.7% |
| Abdominal Pain |
2.2% |
| Gastritis |
2.2% |
| Hyperuricaemia |
2.2% |
| Pyrexia |
2.2% |
| Renal Failure |
2.2% |
| Anaemia |
1.6% |
|
| Rash |
17.0% |
| Renal Failure |
14.9% |
| Drug Hypersensitivity |
8.5% |
| Renal Disorder |
6.4% |
| Skin Ulcer |
6.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| Vomiting |
6.4% |
| Depressed Level Of Consciousness |
4.3% |
| Skin Test Positive |
4.3% |
| Ventricular Extrasystoles |
4.3% |
| Eczema |
2.1% |
| Generalised Erythema |
2.1% |
| Hepatic Lesion |
2.1% |
| Liver Disorder |
2.1% |
| Multi-organ Failure |
2.1% |
| Nausea |
2.1% |
| Renal Impairment |
2.1% |
| Respiratory Failure |
2.1% |
| Shock |
2.1% |
| Shock Haemorrhagic |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
13.8% |
| Ventricular Tachycardia |
11.4% |
| Pain Management |
11.2% |
| Cardiac Failure |
11.0% |
| Hypertension |
10.3% |
| Drug Use For Unknown Indication |
7.7% |
| Diabetes Mellitus |
4.0% |
| Nerve Injury |
3.7% |
| Prophylaxis |
3.7% |
| Migraine |
3.5% |
| Hypersensitivity |
3.0% |
| Hyperlipidaemia |
2.6% |
| Myotonia |
2.6% |
| Constipation |
2.1% |
| Gastric Ulcer |
1.9% |
| Insomnia |
1.9% |
| Neuropathy Peripheral |
1.6% |
| Arrhythmia |
1.4% |
| Breast Cancer |
1.4% |
| Gastritis |
1.4% |
|
| Dyspnoea Exertional |
9.1% |
| Rash Generalised |
7.8% |
| Renal Failure Acute |
7.8% |
| Sepsis |
7.8% |
| Toxic Epidermal Necrolysis |
7.8% |
| Renal Failure |
6.5% |
| Ventricular Tachycardia |
6.5% |
| Drug Ineffective |
5.2% |
| Hepatic Function Abnormal |
5.2% |
| Toxic Skin Eruption |
5.2% |
| Blood Lactate Dehydrogenase Increased |
3.9% |
| Stevens-johnson Syndrome |
3.9% |
| Ventricular Extrasystoles |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| Bradycardia |
2.6% |
| Cerebral Infarction |
2.6% |
| Liver Disorder |
2.6% |
| Malaise |
2.6% |
| Pyrexia |
2.6% |
| Rash |
2.6% |
|
| Concomitant |
| Pain |
16.9% |
| Hypertension |
12.6% |
| Prophylaxis |
7.3% |
| Drug Use For Unknown Indication |
7.1% |
| Product Used For Unknown Indication |
6.5% |
| Cardiac Failure |
5.2% |
| Diabetes Mellitus |
4.6% |
| Cancer Pain |
3.8% |
| Insomnia |
3.6% |
| Ventricular Extrasystoles |
3.4% |
| Gastritis |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Arrhythmia |
3.2% |
| Constipation |
3.2% |
| Diabetic Neuropathy |
3.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Depression |
2.8% |
| Atrial Fibrillation |
2.3% |
| Neuralgia |
2.3% |
| Angina Pectoris |
2.3% |
|
| Vomiting |
11.8% |
| Interstitial Lung Disease |
11.3% |
| Pneumonia |
7.2% |
| Sepsis |
6.8% |
| White Blood Cell Count Decreased |
6.3% |
| Hepatic Function Abnormal |
5.4% |
| Ventricular Tachycardia |
5.0% |
| Ventricular Extrasystoles |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Cardiac Failure |
4.1% |
| Upper Gastrointestinal Haemorrhage |
4.1% |
| Drug Prescribing Error |
3.6% |
| Liver Disorder |
3.6% |
| Somnolence |
3.6% |
| Death |
3.2% |
| Hypoglycaemia |
3.2% |
| Nausea |
3.2% |
| Stomatitis |
3.2% |
| Overdose |
2.7% |
| Rash |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
23.5% |
| Hypertension |
23.5% |
| Gastrooesophageal Reflux Disease |
11.8% |
| Ventricular Extrasystoles |
11.8% |
| Atrial Fibrillation |
5.9% |
| Back Pain |
5.9% |
| Constipation |
5.9% |
| Oedema |
5.9% |
| Seasonal Allergy |
5.9% |
|
| Torsade De Pointes |
75.0% |
| Cerebral Infarction |
25.0% |
|
